ribavirin has been researched along with Hyperuricemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ammuri, H; Elias, A; Frisch, A; Kurnik, D; Sakran, R; Sliman, H | 1 |
| Chewaproug, D; Knorr, JP; Neeli, S; Torres, E; Zaki, R | 1 |
| Enjoji, M; Higuchi, N; Horikawa, Y; Kato, M; Kinukawa, N; Kotoh, K; Nakamuta, M; Tajiri, H; Takayanagi, R; Ueda, A; Yamashita, N | 1 |
3 other study(ies) available for ribavirin and Hyperuricemia
| Article | Year |
|---|---|
Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effect.
Topics: Acute Kidney Injury; Adult; Creatinine; Humans; Hyperuricemia; Male; Ribavirin; Uric Acid; Young Adult | 2021 |
Severe Interferon/Ribavirin-Induced Hyperuricemia and Urate Nephropathy Requiring Rasburicase and Hemodialysis in a Liver Transplant Recipient.
Topics: Female; Gout Suppressants; Humans; Hyperuricemia; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Middle Aged; Postoperative Complications; Recombinant Proteins; Ribavirin; Urate Oxidase | 2015 |
Investigation of hyperuricemia during pegylated-interferon-alpha2b plus ribavirin combination therapy in patients with chronic hepatitis C.
Topics: Aged; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperuricemia; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Uric Acid | 2008 |